<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2593100-A4" country="EP" doc-number="2593100" kind="A4" date="20140101" family-id="45497391" file-reference-id="252632" date-produced="20180823" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146552030" ucid="EP-2593100-A4"><document-id><country>EP</country><doc-number>2593100</doc-number><kind>A4</kind><date>20140101</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-11810210-A" is-representative="NO"><document-id mxw-id="PAPP154825953" load-source="docdb" format="epo"><country>EP</country><doc-number>11810210</doc-number><kind>A</kind><date>20110717</date><lang>EN</lang></document-id><document-id mxw-id="PAPP220414800" load-source="docdb" format="original"><country>EP</country><doc-number>11810210.2</doc-number><date>20110717</date></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140454373" ucid="US-2011044301-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>2011044301</doc-number><kind>W</kind><date>20110717</date></document-id></priority-claim><priority-claim mxw-id="PPC140454830" ucid="US-36532810-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>36532810</doc-number><kind>P</kind><date>20100717</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1988099230" load-source="docdb">A61K  31/416       20060101ALI20131122BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988112685" load-source="docdb">A61K  31/337       20060101ALI20131122BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988116865" load-source="docdb">A61K  31/255       20060101ALI20131122BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988121878" load-source="docdb">A61K  33/24        20060101AFI20131122BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988122341" load-source="docdb">A61K  31/454       20060101ALI20131122BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988135216" load-source="docdb">A61K  31/445       20060101ALI20131122BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988139326" load-source="docdb">A61P  35/00        20060101ALI20131122BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL1988099972" load-source="docdb" scheme="CPC">A61K  31/454       20130101 LI20130610BHEP        </classification-cpc><classification-cpc mxw-id="PCL1988101307" load-source="docdb" scheme="CPC">A61K  31/555       20130101 FI20130610BHEP        </classification-cpc><classification-cpc mxw-id="PCL1988109709" load-source="docdb" scheme="CPC">A61K  31/445       20130101 LI20130610BHEP        </classification-cpc><classification-cpc mxw-id="PCL1988114367" load-source="docdb" scheme="CPC">A61K  31/255       20130101 LI20130610BHEP        </classification-cpc><classification-cpc mxw-id="PCL1988122833" load-source="docdb" scheme="CPC">A61K  33/24        20130101 LI20130610BHEP        </classification-cpc><classification-cpc mxw-id="PCL1988126933" load-source="docdb" scheme="CPC">A61K  31/337       20130101 LI20130610BHEP        </classification-cpc><classification-cpc mxw-id="PCL1988137216" load-source="docdb" scheme="CPC">A61K  31/416       20130101 LI20130610BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132188574" lang="DE" load-source="docdb">VERFAHREN ZUR BEHANDLUNG VON REFRAKTÄREM KREBS</invention-title><invention-title mxw-id="PT132188575" lang="EN" load-source="docdb">METHOD OF TREATING REFRACTORY CANCER</invention-title><invention-title mxw-id="PT132188576" lang="FR" load-source="docdb">PROCÉDÉ DE TRAITEMENT DE CANCER RÉFRACTAIRE</invention-title><citations><non-patent-citations><nplcit><text>CHRISTIAN G. HARTINGER ET AL: "From bench to bedside - preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)", JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 100, no. 5-6, 1 May 2006 (2006-05-01), pages 891 - 904, XP055088486, ISSN: 0162-0134, DOI: 10.1016/j.jinorgbio.2006.02.013</text><sources><source mxw-id="PNPL67406734" load-source="docdb" name="SEA" category="Y"/></sources></nplcit><nplcit><text>GHOLAM D ET AL: "Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer", ONCOLOGIST 200611 US, vol. 11, no. 10, November 2006 (2006-11-01), pages 1072 - 1080, XP055089123, ISSN: 1083-7159</text><sources><source mxw-id="PNPL67406735" load-source="docdb" name="SEA" category="Y"/></sources></nplcit></non-patent-citations></citations></technical-data><parties><applicants><applicant mxw-id="PPAR918140247" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>NIIKI PHARMA INC</last-name><address><country>US</country></address></addressbook></applicant><applicant mxw-id="PPAR918161997" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>NIIKI PHARMA INC.</last-name></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR918162589" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>SHESHBARADARAN HOOSHMAND</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR918141202" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>SHESHBARADARAN, HOOSHMAND</last-name></addressbook></inventor></inventors></parties><international-convention-data><designated-states><ep-contracting-states><country mxw-id="DS548871909" load-source="docdb">AL</country><country mxw-id="DS548844057" load-source="docdb">AT</country><country mxw-id="DS548871910" load-source="docdb">BE</country><country mxw-id="DS548953719" load-source="docdb">BG</country><country mxw-id="DS548931728" load-source="docdb">CH</country><country mxw-id="DS548947188" load-source="docdb">CY</country><country mxw-id="DS548844058" load-source="docdb">CZ</country><country mxw-id="DS548871911" load-source="docdb">DE</country><country mxw-id="DS548947189" load-source="docdb">DK</country><country mxw-id="DS548947190" load-source="docdb">EE</country><country mxw-id="DS548820356" load-source="docdb">ES</country><country mxw-id="DS548953720" load-source="docdb">FI</country><country mxw-id="DS548931729" load-source="docdb">FR</country><country mxw-id="DS548871912" load-source="docdb">GB</country><country mxw-id="DS548947191" load-source="docdb">GR</country><country mxw-id="DS548871913" load-source="docdb">HR</country><country mxw-id="DS548844059" load-source="docdb">HU</country><country mxw-id="DS548820357" load-source="docdb">IE</country><country mxw-id="DS548947192" load-source="docdb">IS</country><country mxw-id="DS548931730" load-source="docdb">IT</country><country mxw-id="DS548947193" load-source="docdb">LI</country><country mxw-id="DS548953721" load-source="docdb">LT</country><country mxw-id="DS548942447" load-source="docdb">LU</country><country mxw-id="DS548953722" load-source="docdb">LV</country><country mxw-id="DS548953723" load-source="docdb">MC</country><country mxw-id="DS548942448" load-source="docdb">MK</country><country mxw-id="DS548942449" load-source="docdb">MT</country><country mxw-id="DS548820358" load-source="docdb">NL</country><country mxw-id="DS548943416" load-source="docdb">NO</country><country mxw-id="DS548820359" load-source="docdb">PL</country><country mxw-id="DS548942450" load-source="docdb">PT</country><country mxw-id="DS548931731" load-source="docdb">RO</country><country mxw-id="DS548942451" load-source="docdb">RS</country><country mxw-id="DS548820360" load-source="docdb">SE</country><country mxw-id="DS548844060" load-source="docdb">SI</country><country mxw-id="DS548943417" load-source="docdb">SK</country><country mxw-id="DS548943418" load-source="docdb">SM</country><country mxw-id="DS548953724" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data></bibliographic-data><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
